US nutra firm to up share of Chinese herb market

Related tags Revenue

Florida-based nutritional supplements company Bio-One has signed an
agreement to acquire a majority share in a Chinese herbal medicine
company in the Guangzhou Province.

Bio-One hopes to acquire a 51% interest in the company - an integrated business including research and development, manufacturing, sales and marketing - which reported revenues of $10 million in 2003 and has an operating profit of $2.7 million.

This move forms part of Bio-One's desire to establish a real presence in China; a process it began in April when it took majority control of WeiFang Shengtai Pharmaceuticals, a Shandong Province-based manufacturer and distributor of glucose that reported $16.3 million in sales in 2003 and a net income of $2.3 million.

Bio-One has formerly agreed two other majority stakes in Chinese herbal medicine companies. In March the organisation signed an agreement to acquire a 51 per cent interest in a company which reported sales of $20 million in 2003 and in May it agreed a 51 per cent interest in a Hebei Province-based firm, which reported sales of $9 million last year.

Bio-One president and CEO Armand Dauplaise said of the latest accord: "This will be our fourth step in establishing a presence in China. We are aggressively pursuing additional synergistic candidates in China and North America that meet our criteria for profitability and revenue growth."

Bio-One's current subsidiaries include PNLabs, American Nutritional Exchange, Interactive Nutrition International, Nutrition Sciences and WeiFang Shengtai Pharmaceuticals.

"There has been much interest in China for a long time and we are one of the lucky few companies that has been able to close a deal with a pharmaceutical company,"​ said a spokesperson for Bio-One. "We hope to finalise details with the herbal medicine company in the third quarter of this financial year and then increase our revenue stream to enable us to spin-off Bio-One China."

Bio-One hopes this will be followed by an expansion of its distribution channel to market products to traditional drugstores, hospitals and wholesale distributors throughout China.

Related topics Suppliers Polyphenols

Related news

Related products

Related suppliers

Follow us

Products

View more

Webinars